DK1308507T3 - Monoklonalt antistof mod HCV-kerneantigen - Google Patents

Monoklonalt antistof mod HCV-kerneantigen

Info

Publication number
DK1308507T3
DK1308507T3 DK02257622T DK02257622T DK1308507T3 DK 1308507 T3 DK1308507 T3 DK 1308507T3 DK 02257622 T DK02257622 T DK 02257622T DK 02257622 T DK02257622 T DK 02257622T DK 1308507 T3 DK1308507 T3 DK 1308507T3
Authority
DK
Denmark
Prior art keywords
core antigen
hcv core
monoclonal antibody
antibodies
hcv
Prior art date
Application number
DK02257622T
Other languages
English (en)
Inventor
Chander Bahl
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Application granted granted Critical
Publication of DK1308507T3 publication Critical patent/DK1308507T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/116—Togaviridae (F); Matonaviridae (F); Flaviviridae (F)
    • C07K16/118—Hepatitis C virus; GB virus C [GBV-C]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK02257622T 2001-11-05 2002-11-04 Monoklonalt antistof mod HCV-kerneantigen DK1308507T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33745301P 2001-11-05 2001-11-05
US10/268,561 US7049060B2 (en) 2001-11-05 2002-10-10 HCV anti-core monoclonal antibodies

Publications (1)

Publication Number Publication Date
DK1308507T3 true DK1308507T3 (da) 2008-05-19

Family

ID=26953173

Family Applications (2)

Application Number Title Priority Date Filing Date
DK02257622T DK1308507T3 (da) 2001-11-05 2002-11-04 Monoklonalt antistof mod HCV-kerneantigen
DK07075928.7T DK1881064T3 (da) 2001-11-05 2002-11-04 HCV-anti-kerne monoklonalt antistof

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK07075928.7T DK1881064T3 (da) 2001-11-05 2002-11-04 HCV-anti-kerne monoklonalt antistof

Country Status (9)

Country Link
US (1) US7049060B2 (da)
EP (3) EP2186884A3 (da)
JP (1) JP2004035534A (da)
AT (2) ATE459706T1 (da)
CA (1) CA2406240C (da)
DE (2) DE60224346T2 (da)
DK (2) DK1308507T3 (da)
ES (2) ES2295292T3 (da)
PT (2) PT1308507E (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8658773B2 (en) 2011-05-02 2014-02-25 Immunomedics, Inc. Ultrafiltration concentration of allotype selected antibodies for small-volume administration
US7902338B2 (en) 2003-07-31 2011-03-08 Immunomedics, Inc. Anti-CD19 antibodies
JP2009018990A (ja) * 2005-10-25 2009-01-29 Univ Kurume Ｃ型肝炎ウイルス由来ペプチド
US7858752B2 (en) 2006-12-05 2010-12-28 Abbott Laboratories Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
ES3000111T3 (en) 2009-02-13 2025-02-27 Immunomedics Inc Intermediates for preparing conjugates with an intracellularly-cleavable linkage
US20160095939A1 (en) 2014-10-07 2016-04-07 Immunomedics, Inc. Neoadjuvant use of antibody-drug conjugates
EP2478110B1 (en) 2009-09-16 2016-01-06 Immunomedics, Inc. Class i anti-cea antibodies and uses thereof
ES2978177T3 (es) 2009-12-02 2024-09-06 Immunomedics Inc Combinación de radio inmunoterapia y conjugados anticuerpo-fármaco para mejorar la terapia contra el cáncer
WO2012006500A2 (en) * 2010-07-08 2012-01-12 Abbott Laboratories Monoclonal antibodies against hepatitis c virus core protein
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
CN104379169A (zh) 2012-08-14 2015-02-25 Ibc药品公司 用于治疗疾病的t-细胞重定向双特异性抗体
CN107753954A (zh) 2012-12-13 2018-03-06 免疫医疗公司 功效改进且毒性降低的抗体与sn‑38的免疫缀合物的剂量
WO2017004144A1 (en) 2015-07-01 2017-01-05 Immunomedics, Inc. Antibody-sn-38 immunoconjugates with a cl2a linker
WO2014143343A1 (en) * 2013-03-14 2014-09-18 Abbott Laboratories Hcv core lipid binding domain monoclonal antibodies
MX362075B (es) 2013-03-14 2019-01-07 Abbott Lab Ensayo de combinación de antígeno-anticuerpo del virus de la hepatitis c (vhc) y métodos y composiciones para usarlo.
JP2016512241A (ja) 2013-03-14 2016-04-25 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ 改良された抗体検出のためのｈｃｖｎｓ３組換え抗原およびこの突然変異体
JP6447933B2 (ja) 2014-02-21 2019-01-09 アイビーシー ファーマスーティカルズ，インコーポレイテッド Ｔｒｏｐ−２発現細胞に対する免疫応答を誘発することによる疾患治療
CA2935748A1 (en) 2014-02-25 2015-09-03 Immunomedics, Inc. Humanized rfb4 anti-cd22 antibody
EP3160504B1 (en) 2014-06-24 2020-09-16 Immunomedics, Inc. Anti-histone therapy for vascular necrosis in severe glomerulonephritis
AU2016252771B2 (en) 2015-04-22 2021-12-16 Immunomedics, Inc. Isolation, detection, diagnosis and/or characterization of circulating Trop-2-positive cancer cells
JP6980980B2 (ja) 2015-06-25 2021-12-15 イミューノメディクス、インコーポレイテッドImmunomedics, Inc. 抗ｈｌａ‐ｄｒまたは抗ｔｒｏｐ‐２抗体と微小管阻害剤、ｐａｒｐ阻害剤、ブルトンキナーゼ阻害剤またはホスホイノシチド３‐キナーゼ阻害剤との併用は癌の治療効果を有意に改善する
ES2796479T3 (es) 2016-05-31 2020-11-27 Hoffmann La Roche Procedimiento de pretratamiento para la detección rápida del antígeno central del VHC
JP2019523863A (ja) 2016-05-31 2019-08-29 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ ウイルス抗原の血清学的検出方法
JP7068323B2 (ja) 2017-02-02 2022-05-16 エフ．ホフマン－ラ ロシュ アーゲー 少なくとも２種のペグ化された分析物特異的結合剤を使用する免疫アッセイ
CN110996986B (zh) 2017-07-27 2024-07-19 豪夫迈·罗氏有限公司 Hcv抗原的多表位融合蛋白及其用途
CN109738648B (zh) * 2018-12-29 2021-09-17 山东莱博生物科技有限公司 稳定高效表达丙型肝炎病毒核心抗原抗体的工程细胞株及其应用
WO2022239720A1 (ja) 2021-05-10 2022-11-17 公益財団法人川崎市産業振興財団 抗原への結合親和性を低減させた抗体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0185373B1 (ko) 1989-03-17 1999-05-01 로버트 피. 블랙버언 Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용
DE4209215A1 (de) * 1991-07-04 1993-01-07 Boehringer Mannheim Gmbh Hcv peptidantigene und verfahren zur bestimmung von hcv
ZA927837B (en) 1991-10-15 1994-03-11 Akzo Nv Monoclonal antibodiesto hepatitis C virus
JP3217600B2 (ja) * 1994-07-12 2001-10-09 株式会社先端生命科学研究所 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
FR2775690B1 (fr) 1998-03-09 2001-12-14 Bio Merieux Anticorps monoclonal et utilisations pour detecter des antigenes de la proteine core de vhc
US20030022155A1 (en) * 1999-04-14 2003-01-30 Agata Budkowska Method for detecting hepatitis c virus with hybridomas
SI1354204T2 (sl) * 2000-06-15 2010-09-30 Novartis Vaccines & Diagnostic Hcv antigen antitelo kombinacijska analiza
JP4353793B2 (ja) * 2001-06-26 2009-10-28 アボット・ラボラトリーズ Ｈｃｖ抗原とｈｃｖ抗体との同時検出のための方法

Also Published As

Publication number Publication date
EP1308507A3 (en) 2003-10-22
EP1308507A2 (en) 2003-05-07
EP1881064A2 (en) 2008-01-23
EP1881064A3 (en) 2008-04-09
ES2295292T3 (es) 2008-04-16
ES2339709T3 (es) 2010-05-24
ATE382683T1 (de) 2008-01-15
CA2406240A1 (en) 2003-05-05
DE60224346D1 (de) 2008-02-14
CA2406240C (en) 2011-01-04
EP2186884A3 (en) 2010-09-08
PT1308507E (pt) 2008-03-31
DK1881064T3 (da) 2010-06-07
EP1881064B1 (en) 2010-03-03
JP2004035534A (ja) 2004-02-05
PT1881064E (pt) 2010-03-31
EP1308507B1 (en) 2008-01-02
EP2186884A2 (en) 2010-05-19
DE60224346T2 (de) 2008-12-24
US7049060B2 (en) 2006-05-23
DE60235588D1 (de) 2010-04-15
US20030148333A1 (en) 2003-08-07
ATE459706T1 (de) 2010-03-15

Similar Documents

Publication Publication Date Title
DK1308507T3 (da) Monoklonalt antistof mod HCV-kerneantigen
DK1716181T3 (da) CDR-reparerede antistoffer
DK1414858T3 (da) Kamelid-enkeltkæde-VHH-antistoffer, fremgangsmåde til fremstilling heraf i et pattedyr samt anvendelser heraf
NO2017032I1 (no) bezlotoksumab
NO20054351D0 (no) Monoklonalt antistoff og hybridom som produserer dette
EP1651659A4 (en) METHOD FOR HUMANIZATION OF MONOCLONAL RABBIT ANTIBODIES
ATE520716T1 (de) Humanisierter anti-cd4-antikörper mit immunsuppressiven eigenschaften
GB2383331A (en) Monoclonal antibody DS6 Tumor-associated antigen CA6 and methods of use thereof
DE60222658D1 (de) Monoklonaler anti-cd-40-antikörper
NO20071436L (no) Humaniserte Anti-5T4 antistoffer og Anti-5T4 antistoff/calicheamicin konjugater
DE60334076D1 (de) Monoklonaler anti-mensch-tenascin-Antikörper
DK1167389T3 (da) Antistoffer mod SEMP1-proteinet, fremgangsmåde til fremstilling heraf samt anvendelse deraf
DE60045870D1 (de) Monoklonaler antikörper, hybridoma, immuntestverfahren und diagnosekit
BR0015872A (pt) Agentes antitrombóticos
ATE162553T1 (de) Monoklonale antikörper gegen hepatitis-c-virus
AU2003283240A8 (en) Antibody for isolating and/or identifying mesenchymal stem cells and method for isolating and/or identifying mesenchymal stem cells
DK0569537T3 (da) Monoklonale antistoffer mod formodede HCV-kapperegioner og fremgangsmåder til anvendelse deraf
DK0556320T3 (da) Monoklonale antistoffer mod Hepatitis C-virus og fremgangsmåde til anvendelse heraf
FI20011055A0 (fi) Heveiiniä sitovat monoklonaaliset vasta-aineet
BR0204612A (pt) Anticorpos monoclonais antinúcleo de hcv
DK0599913T3 (da) Monoklonale antistoffer mod formodet hepatitis C-virus NS5-proteiner og anvendelsesmetoder af samme
AR037216A1 (es) Anticuerpos monoclonales antinucleares de hcv
EP1483292A4 (en) MONOCLONAL ANTIBODIES WITH CROSS-REACTION AGAINST BACTERIAL COLLAGEN BINDING PROTEINS